Siamab Therapeutics is a bio-pharmaceutical company developing therapies targeting cancers that express abnormal carbohydrates/glycans.
Location: United States, Massachusetts, Newton
Investors 3
Mentions in press and media 2
| Date | Title | Description |
| 14.07.2014 | Siamab Therapeutics: New funding, new name, new direction in cancer immunotherapy | Siamab has identified highly specific antibodies that have the potential to not only kill tumor cells, but also inhibit cancer progression, Behrens said. Siamab targets abnormal carbohydrates, or glycans, that are only found on the outer su... |
| - | Siamab Therapeutics: New funding, new name, new direction in cancer immunotherapy | Cambridge startup Siamab Therapeutics has changed up its direction, now developing monoclonal antibodies to hinder the progressive growth of tumors. The company just received another $2 million in funding, largely from angel investors, roun... |